Pangraf – Tacrolimus Capsule
TACROLIMUS (PANGRAF) CAPSULE – TREATMENT FOR PREVENTION OF ORGAN REJECTION IN TRANSPLANT PATIENTS
In order to stop your body from rejecting a new organ (such as a liver, kidney, or heart) following a transplant, Pangraf Capsule is taken in combination with other medications. In order to prevent your immune system from attacking the new organ, it does this by weakening it. This medicine is a member of the immunosuppressant drug class.
Your body weight, the type of transplant you had, and any other medications you are currently taking will all affect how much and how frequently you should take Pangraf Capsule.
USES OF TACROLIMUS (PANGRAF) CAPSULE
- Prevention of organ rejection in transplant patients
WORKS OF TACROLIMUS (PANGRAF) CAPSULE
Pangraf Capsule suppresses the immune system. It functions by reducing your body’s immunological reaction after an organ transplant (e.g., liver, kidney, heart). This aids in the new organ being accepted by your body as if it were your own.
SIDE EFFECTS OF TACROLIMUS (PANGRAF) CAPSULE
- The increased glucose level in blood
- Increased thirst
- Kidney damage
- Liver damage
- Stomach pain
WARNING & PRECAUTIONS
Pangraf Capsule may impair eyesight, reduce alertness, or induce sleep and dizziness. If you experience these symptoms, don’t drive.
Patients with kidney conditions should use Pangraf Capsule cautiously. Pangraf Capsule dosage may need to be changed. Please speak with your physician.
Patients with liver conditions should use Pangraf Capsule cautiously. Pangraf Capsule dosage may need to be changed. Please speak with your physician.
Fedelty Health Care is a Tacrolimus third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.